Source: PR Newswire

Fusion Pharma: INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Fusion Pharmaceuticals Inc. - FUSN

/PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the...

Read full article »
Annual Revenue
$100K-5.0M
Employees
100-250
John Valliant's photo - CEO of Fusion Pharma

CEO

John Valliant

CEO Approval Rating

90/100

Read more